A Multicenter, Open-Label, Phase 2 Study of SyB L-0501 (Bendamustine Hydrochloride) for Patients With Multiple Myeloma.
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2013
At a glance
- Drugs Bendamustine (Primary) ; Prednisolone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 01 Sep 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Aug 2010 New trial record